Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Meeting abstract

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients

Authors: Z Majláth, G Veres, D Zádori, A Balog, N Watti, J Tajti, L Vécsei

Published in: The Journal of Headache and Pain | Special Issue 1/2014

Login to get access

Excerpt

Alterations of the serotoninergic system are well-known in migraine, however, the other main route of tryptophan metabolism, the kynurenine pathway has not yet been investigated in migraine. Psychiatric comorbidity, especially depression is highly frequent in migraine patients, but the exact pathomechanism is not fully clarified. …
Metadata
Title
EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
Authors
Z Majláth
G Veres
D Zádori
A Balog
N Watti
J Tajti
L Vécsei
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-E17

Other articles of this Special Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue

Meeting abstract

EHMTI-0233. Clinical characteristics of migraine patients with dopaminergic gene polymorphisms RS1611115

Meeting abstract

EHMTI-0273. Onabotulinotoxin type A is a therapeutic option in chronic cluster headache

Meeting abstract

EHMTI-0312. Long term efficiency and tolerability of greater occipital nerve infiltrations in primary headache disorders

Meeting abstract

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study

Meeting abstract

EHMTI-0290. Headaches in patients with autism spectrum disorder

Meeting abstract

EHMTI-0250. General practitioners’ experiences with brief intervention for medication-overuse headache: a qualitative study